Cargando…

Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens

Chronic hepatitis B virus (HBV) infection affects 240 to 300 million people worldwide. In the nucleus of infected hepatocytes, the HBV genome is converted to covalently closed circular DNA (cccDNA), which persists and serves as a transcriptional template for viral progeny. Therefore, a long-term cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gish, Robert G, Asselah, Tarik, Squires, Katherine, Mayers, Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703507/ https://www.ncbi.nlm.nih.gov/pubmed/36423233 http://dx.doi.org/10.1177/20402066221138705

Ejemplares similares

A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI‐2173 in patients with chronic hepatitis B virus infection
por: Squires, Katherine E., et al.
Publicado: (2022)

ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
por: Squires, Katherine E., et al.
Publicado: (2020)

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023)

Establishment of a system for finding inhibitors of ε RNA binding with the HBV polymerase
por: Liu, Xiao‐Quan, et al.
Publicado: (2020)

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
por: Ju, Jingyue, et al.
Publicado: (2020)

Commentary on: A study of genotype, mutants and nucleotide sequence of HBV in Pakistan: Genotype, mutants, and nucleotide sequence of HBV
por: Jazayeri, Seyed Mohammad
Publicado: (2011)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
por: Moini, Maryam, et al.
Publicado: (2022)

Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase
por: Chien, Minchen, et al.
Publicado: (2020)

Medical interventions associated with HBV reactivation: Common and less common
por: Reynolds, Justin A., et al.
Publicado: (2015)

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
por: Zhang, Qingrong, et al.
Publicado: (2023)

Exploiting the Nucleotide Substrate Specificity of Repair DNA Polymerases To Develop Novel Anticancer Agents
por: Crespan, Emmanuele, et al.
Publicado: (2011)

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
por: Yang, Yu-Chan, et al.
Publicado: (2021)

Drug Discovery Study Aimed at a Functional Cure for HBV
por: Watanabe, Takehisa, et al.
Publicado: (2022)

GE23077 binds to the RNA polymerase ‘i’ and ‘i+1’ sites and prevents the binding of initiating nucleotides
por: Zhang, Yu, et al.
Publicado: (2014)

Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus
por: Feng, Joy Y., et al.
Publicado: (2016)

Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development?
por: Vaillant, Andrew
Publicado: (2022)

128 Cure of HBV infection: can APOBEC3 deaminases mediate it?
por: Protzer, Ulrike
Publicado: (2014)

Fine‐Tuning TLR‐7‐Based Therapy for Functional HBV Cure
por: Bertoletti, Antonio, et al.
Publicado: (2019)

High rates of hepatitis B virus (HBV) functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy
por: Xia, Huan, et al.
Publicado: (2022)

Liver sampling: a vital window into HBV pathogenesis on the path to functional cure
por: Gill, Upkar S, et al.
Publicado: (2018)

Pathway to global elimination of hepatitis B: HBV cure is just the first step
por: Howell, Jessica, et al.
Publicado: (2023)

Discovery and Development of Anti-HBV Agents and Their Resistance
por: Kim, Kyun-Hwan, et al.
Publicado: (2010)

Synthetic Nucleotides as Probes of DNA Polymerase Specificity
por: Walsh, Jason M., et al.
Publicado: (2012)

A Model for the Evolution of Nucleotide Polymerase Directionality
por: Ballanco, Joshua, et al.
Publicado: (2011)

Uncovering the Polymerase-induced Cytotoxicty of an Oxidized Nucleotide
por: Freudenthal, Bret D., et al.
Publicado: (2014)

Dissecting nucleotide selectivity in viral RNA polymerases
por: Long, Chunhong, et al.
Publicado: (2021)

Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
por: Loureiro, Dimitri, et al.
Publicado: (2019)

Inhibition studies of HBV DNA polymerase using seed extracts of Pongamia pinnata
por: Mathayan, Manikannan, et al.
Publicado: (2019)

Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients
por: Shokatpour, Narjes, et al.
Publicado: (2019)

Computational Investigation of Locked Nucleic Acid (LNA) Nucleotides in the Active Sites of DNA Polymerases by Molecular Docking Simulations
por: Poongavanam, Vasanthanathan, et al.
Publicado: (2014)

“Gate-keeper” Residues and Active-Site Rearrangements in DNA Polymerase μ Help Discriminate Non-cognate Nucleotides
por: Li, Yunlang, et al.
Publicado: (2013)

The influence of the 5΄-terminal nucleotide on AgoshRNA activity and biogenesis: importance of the polymerase III transcription initiation site
por: Herrera-Carrillo, Elena, et al.
Publicado: (2017)

Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication
por: Dejmek, Milan, et al.
Publicado: (2021)

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents
por: Kakiuchi, Toshihiko
Publicado: (2023)

INCORPORATION OF NUCLEOTIDES INTO NUCLEI OF FIXED CELLS BY DNA POLYMERASE
por: von Borstel, R. C., et al.
Publicado: (1966)

Antibody–nucleotide conjugate as a substrate for DNA polymerases
por: Balintová, J., et al.
Publicado: (2018)

Therminator DNA Polymerase: Modified Nucleotides and Unnatural Substrates
por: Gardner, Andrew F., et al.
Publicado: (2019)

DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration sites
por: Wu, Canbiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_24trrh17rliffk4kmioo432m2a